A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Huashan Hospital Affiliated to Fudan University, Shanghai, China
Contact: Study coordinator (Jing Zhang, PhD) · Zhangj_fudan@163.com · 86-021-52887926
Huashan Hospital Affiliated to Fudan University, Shanghai, China
Contact: Study coordinator (Jinhua Xu, PhD) · xjhhsyy@163.com · 86-021-52887783

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Atopic Dermatitis (AD) · Eczema

Abroad (travel likely)RecruitingPHASE1

Fair Lawn, United States

HL-300 Ointment in Patients With Mild-to-Moderate Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hangzhou, China

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

Atopic Dermatitis · Atopic · Dermatitis

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Birmingham, United States

A Study Evaluating BFB759 in Moderate to Severe Atopic Dermatitis

Atopic Dermatitis (AD)

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Phoenix, United States